Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo

B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is the most frequent malignancy in children and also occurs in adulthood. Despite high cure rates, BCP-ALL chemotherapy can be highly toxic. This type of toxicity can most likely be reduced by antibody-based immunotherapy targeting the CD19 ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Winterberg, Dorothee, Lenk, Lennart, Oßwald, Maren, Vogiatzi, Fotini, Gehlert, Carina Lynn, Frielitz, Fabian-Simon, Klausz, Katja, Rösner, Thies, Valerius, Thomas, Trauzold, Anna, Peipp, Matthias, Kellner, Christian, Schewe, Denis Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232684/
https://www.ncbi.nlm.nih.gov/pubmed/34203833
http://dx.doi.org/10.3390/jcm10122634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232684/
https://www.ncbi.nlm.nih.gov/pubmed/34203833
http://dx.doi.org/10.3390/jcm10122634

Ejemplares similares